AlloVir Inc Ordinary Shares (NASDAQ:ALVR)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ALVR

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ALVR

  • Market Cap$1.280bn
  • SymbolNASDAQ:ALVR
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS0198181036

Company Profile

AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.

Latest ALVR news

Currently there for this company. Visit our news hub for other news .